Specialty RxGuidance


The Specialty Drug Problem

Pill_Icon

RISING COSTS

The trend of rising pharmaceutical costs will continue, driven by expensive specialty drugs.
Stats_Icon

PHYSICIANS CAN BE INFLUENCED

Prescribing physicians can be influenced by pharmaceutical representatives and rarely have current information regarding the cost of drugs to the member or the plan.
Cost_Icon

CONFLICTS OF INTEREST

Conflicts of interest abound since Pharmacy Benefit Management companies have financial ties to pharmaceutical manufacturers and many even own their own specialty pharmacy.
Checklist_Icon

MEMBERS CAN BE INFLUENCED

Members can be influenced by specialty drug advertising, creating demand for high-cost drugs with no knowledge of their cost or less expensive alternatives.
SpecialtyDrugReportButton-18

By the Numbers

In 2015 – 50% of the drugs approved by the FDA were specialty drugs. The market has been bombarded with high-cost drugs over the last few years.
Most of these drugs cannot be substituted with a generic or lower-cost alternative.
Treatment regimens can be very costly, some reaching as much as $750,000/year.
The average annual cost increase of Specialty Drugs is 21% based on a three year trend.

So, what's the solution?

Independent, Unbiased Prior Authorization

of Specialty Drugs

RxResults removes the conflict of interest.

Our model is designed to make certain the right member meeting the right clinical criteria gets the right drug at the right time in an effort to achieve the best clinical outcome.

RxResults has a marked advantage due to their relationship with the nationally recognized University of Arkansas for Medical Sciences' College of Pharmacy.

RxResults provides independent, non-biased clinical prior authorization review of specialty drugs. PBMs still provide pharmacy benefit management services & specialty pharmacy services, including fulfillment of specialty drugs.


Download the RxResults Solutions Brochure

HEARD ENOUGH?

START THE CONVERSATION